Risk of significant cytopenias after treatment with tocilizumab in systemic juvenile arthritis patients with a history of macrophage activation syndrome (Q42378160)

From Wikidata
Jump to navigation Jump to search
scientific article published on 29 August 2012
edit
Language Label Description Also known as
English
Risk of significant cytopenias after treatment with tocilizumab in systemic juvenile arthritis patients with a history of macrophage activation syndrome
scientific article published on 29 August 2012

    Statements

    Risk of significant cytopenias after treatment with tocilizumab in systemic juvenile arthritis patients with a history of macrophage activation syndrome (English)
    1 reference
    Elizabeth A Kessler
    1 reference
    Sheetal S Vora
    1 reference
    James W Verbsky
    1 reference
    29 August 2012
    1 reference
    10
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit